Development of Dolutegravir Single-entity and Fixed-dose Combination Formulations for Children. Singh RP, Adkison KK, Baker M, Parasrampuria R, et al. Pediatr Infect Dis J 2021 Oct 12. pii: 00006454-900000000-95623.

Read + Share

Amedeo Smart

Independent Medical Education

Singh RP, Adkison KK, Baker M, Parasrampuria R, et al. Development of Dolutegravir Single-entity and Fixed-dose Combination Formulations for Children. Pediatr Infect Dis J 2021 Oct 12. pii: 00006454-900000000-95623.
PMID: 34817414